38 related articles for article (PubMed ID: 25782917)
1. Circulating MicroRNA-21 Expression as a Novel Serum Biomarker for Oral Sub-Mucous Fibrosis and Oral Squamous Cell Carcinoma.
Singh P; Srivastava AN; Sharma R; Mateen S; Shukla B; Singh A; Chandel S
Asian Pac J Cancer Prev; 2018 Apr; 19(4):1053-1057. PubMed ID: 29699056
[TBL] [Abstract][Full Text] [Related]
2. Fibroblast Growth Factor (FGF-2) and Its Receptors FGFR-2 and FGFR-3 May Be Putative Biomarkers of Malignant Transformation of Potentially Malignant Oral Lesions into Oral Squamous Cell Carcinoma.
Nayak S; Goel MM; Makker A; Bhatia V; Chandra S; Kumar S; Agarwal SP
PLoS One; 2015; 10(10):e0138801. PubMed ID: 26465941
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Platelet Parameters in Oral Submucous Fibrosis and Oral Squamous Cell Carcinoma in a Background of Oral Submucous Fibrosis.
Ranjitham PS; Kuzhali S; Sumathy MP; Gnandeepam S
Indian J Dent Res; 2023 Oct; 34(4):417-421. PubMed ID: 38739824
[TBL] [Abstract][Full Text] [Related]
4. Expression Profile of Circulating Exosomal microRNAs in Leukoplakia, Oral Submucous Fibrosis, and Combined Lesions of Leukoplakia and Oral Submucous Fibrosis.
Yasothkumar D; Ramani P; Jayaraman S; Ramalingam K; Tilakaratne WM
Head Neck Pathol; 2024 Mar; 18(1):28. PubMed ID: 38536520
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of possible role of fluoride in pathogenesis of oral submucous fibrosis: A pilot study.
Arakeri G; Rao Us V; Patil S; Kunigal S; Reddy R; Krishnan M; Hale B; Brennan PA
J Oral Pathol Med; 2024 Mar; 53(3):226-231. PubMed ID: 38417414
[TBL] [Abstract][Full Text] [Related]
6. The Stromal Dictators in a Concomitant Case of Oral Submucous Fibrosis - Oral Squamous Cell Carcinoma.
Mukherjee A; Spadigam A; Dhupar A
Int J Appl Basic Med Res; 2020; 10(3):215-217. PubMed ID: 33088747
[TBL] [Abstract][Full Text] [Related]
7. Expression of Proliferating Cell Nuclear Antigen (PCNA) in Oral Submucous Fibrosis: An Immunohistochemical Study.
Keshav R; Narayanappa U
J Clin Diagn Res; 2015 May; 9(5):ZC20-3. PubMed ID: 26155556
[TBL] [Abstract][Full Text] [Related]
8. Correlation between Vascularity and Advancing Histological Grades of Oral Submucous Fibrosis with a Plausible Role in Malignisation: Systematic review of a persisting matter of conflict.
Pandiar D; Nair SK; Bologna-Molina R; Krishnan RP; Sivakumar N; Anand R; Chaudhari S; Sharma P
Sultan Qaboos Univ Med J; 2024 May; 24(2):152-160. PubMed ID: 38828241
[TBL] [Abstract][Full Text] [Related]
9. Enzyme-linked immunosorbent assay and immunohistochemical analysis of mast cell related biochemicals in oral submucous fibrosis.
Gharote H; Bhowate R; Dangore-Khasbage S
F1000Res; 2023; 12():1288. PubMed ID: 38826574
[TBL] [Abstract][Full Text] [Related]
10. A novel histological grading system for minor salivary gland involvement in oral submucous fibrosis patients with clinico-pathological validation.
Ingle Y; Sarode GS; Sarode SC
J Oral Biol Craniofac Res; 2021; 11(4):596-600. PubMed ID: 34557379
[TBL] [Abstract][Full Text] [Related]
11. Lactate Dehydrogenase as a Biomarker in Oral Submucous Fibrosis: A Systematic Review and Meta-Analysis.
Mahapatra M; Panda A; Kumar H; Barman D; Talukdar R; Dakshinakabat P
Cureus; 2023 Dec; 15(12):e51008. PubMed ID: 38264399
[TBL] [Abstract][Full Text] [Related]
12. Exploratory Study on Micronuclei and Metanuclear Abnormalities in Exfoliated Buccal Cells of COVID-19 Suspected Patients.
Vishnu B; Murugan S; Kalidoss VK; Sesham K; Ramamurthy S; Bakshi SS; Francis YM; Kasirajan SP
J Cytol; 2024; 41(1):28-33. PubMed ID: 38282807
[TBL] [Abstract][Full Text] [Related]
13. The adverse effects of mining pollutants on oral mucosa in Bellary district: A clinical and genotoxicity study.
Bellary IR; Prabhu VD; Jose M; Abdulla R; Shetty UA
J Oral Maxillofac Pathol; 2024; 28(1):90-95. PubMed ID: 38800431
[TBL] [Abstract][Full Text] [Related]
14. Quantitative evaluation of micronuclei in oral squamous cell carcinoma and oral submucous fibrosis patients: a comparative study.
Shah SN; Manjunatha BS; Shah VS; Dagrus K; Soni N; Shah S
Recent Pat Anticancer Drug Discov; 2015; 10(2):233-8. PubMed ID: 25782917
[TBL] [Abstract][Full Text] [Related]
15. Oral squamous cell carcinoma in the background of oral submucous fibrosis is a distinct clinicopathological entity with better prognosis.
Gadbail AR; Chaudhary M; Gawande M; Hande A; Sarode S; Tekade SA; Korde S; Zade P; Bhowate R; Borle R; Patil S
J Oral Pathol Med; 2017 Jul; 46(6):448-453. PubMed ID: 28129456
[TBL] [Abstract][Full Text] [Related]
16. Molecular profiling of oral squamous cell carcinoma associated with oral submucous fibrosis.
Choudhari S; Masne S; Bhandare P; Dhumal S
J Cancer Res Ther; 2022; 18(1):55-65. PubMed ID: 35381762
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of stromal myofibroblasts in oral leukoplakia, oral submucous fibrosis, and oral squamous cell carcinoma--an immunohistochemical study.
Gupta K; Metgud R; Gupta J
J Cancer Res Ther; 2015; 11(4):893-8. PubMed ID: 26881537
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological characteristics of oral squamous cell carcinoma arising from oral submucous fibrosis: A systematic review.
Divya B; Vasanthi V; Ramadoss R; Kumar AR; Rajkumar K
J Cancer Res Ther; 2023; 19(3):537-542. PubMed ID: 37470571
[TBL] [Abstract][Full Text] [Related]
19. Comparison of Immunohistochemical Markers in Oral Submucous Fibrosis and Oral Submucous Fibrosis Transformed to Oral Squamous Cell Carcinoma-A Systematic Review and Meta-Analysis.
Mohapatra D; Panda S; Mohanty N; Panda S; Lewkowicz N; Lapinska B
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511530
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
